ICD-10-CM T45.1X5: Adverse effect of antineoplastic and immunosuppressive drugs

ICD-10-CM Diagnosis Code (2025)

Official Description for T45.1X5

Adverse effect of antineoplastic and immunosuppressive drugs

Parent Code (Less Specific):

About ICD-10-CM Code T45.1X5 (Adverse effect of antineoplastic and immunosuppressive drugs)

ICD-10-CM code T45.1X5 is a billable or specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2025 edition of ICD-10-CM T45.1X5 became effective on October 1, 2024.

This page provides detailed information about T45.1X5 - Adverse effect of antineoplastic and immunosuppressive drugs. It includes common terminology, coding guidelines such as "Includes," "Excludes1," and "Excludes2" notes, and information on required 7th characters. Utilizing this information correctly is essential for accurate medical coding and claims submission for conditions like Adverse effect of antineoplastic and immunosuppressive drugs.